Overexpression of WT1 and PRAME predicts poor outcomes of patients with myelodysplastic syndromes with thrombocytopenia

Qiu-Sha Huang(Peking University), Xiaohui Zhang(Beijing University of Chinese Medicine), Huixin Liu(Peking University), Xiao‐Jun Huang(Peking University), Yi Liu(The University of Texas Southwestern Medical Center), Hongyu Zhang(Chinese PLA General Hospital), Lan‐Ping Xu(Peking University), Jingbo Wang(Tang Du Hospital), Bo Huang(Guangdong Pharmaceutical University), Yuying Liu(Tianjin University of Science and Technology), Qian Jiang(Peking University), Ya‐Zhen Qin(Peking University), Li Su(Capital Medical University), Yanrong Liu(Peking University), Sujun Gao(Jilin University), Qiaozhu Zeng(Peking University), Hao Jiang(Sun Yat-sen University), Zhenling Li(China-Japan Friendship Hospital), Jingzhi Wang(Nantong University), Jin Lu(Peking University)
Blood Advances
November 12, 2019
Cited by 11


Related Papers